National Health (Originator Brand) Amendment Determination 2020 (No. 7) (PB 118 of 2020) (Cth)

PB 118 of 2020

National Health (Originator Brand) Amendment Determination 2020 (No. 7)

I, Thea Connolly, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make the following Determination.

Dated               26 November 2020                 

THEA CONNOLLY

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments  2

National Health (Originator Brand) Determination 2015 (PB 100 of 2015)   2

1  Name

This instrument is the National Health (Originator Brand) Amendment Determination 2020 (No. 7).

This instrument may also be cited as PB 118 of 2020.

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	1 December 2020

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under subsection 99ADB(6B) of the National Health Act 1953

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Originator Brand) Determination 2015 (PB 100 of 2015)

1  Schedule 1, (after table item 7)

Insert:

7A Ambrisentan Volibris

2  Schedule 1, (table item 16, 16A, 16B and 16C)

Repeal the items:

16	Anastrozole	Arimidex
16A	Apomorphine	Apomine Apomine Intermittent Apomine Solution for Infusion
16B	Aripiprazole	Abilify	Oral
		Abilify Maintena	Injection
16C	Atazanavir	Reyataz

Substitute:

16	Anastrozole	Arimidex
16A	Apomorphine	Apomine Apomine Intermittent Apomine Solution for Infusion
16B	Aripiprazole	Abilify	Oral
		Abilify Maintena	Injection
16C	Arsenic	Phenasen
16D	Atazanavir	Reyataz

3  Schedule 1, (after table item 188)

Insert:

188A Posaconazole Noxafil